Minister Vandenbroucke Blocks Reimbursement of Obesity Drug Mounjaro
4 Articles
4 Articles
The treatment, whose price exceeds 170 euros per month for the initial dose, attracts more and more Belgians. Its cost remains entirely at the expense of patients who use it to lose weight. ...
Minister of Public Health Frank Vandenbroucke (Vooruit) has decided not to reimburse the popular obesity drug Mounjaro. This is reported by De Tijd and L'Echo, and the minister confirmed the news to VRT NWS. Vandenbroucke had previously made the same decision for the obesity drug Wegovy.
Minister of Public Health Frank Vandenbroucke does not want the weight-loss drug Mounjaro to be reimbursed. Along with Ozempic and Wegovy, Mounjaro has become an enormously popular medication in recent years for losing weight due to being overweight. Doctor Kaat Ieven, a general practitioner at the De Boxberg group practice in Genk, believes that it should be reimbursed.
Federal Minister of Public Health Frank Vandenbroucke (Vooruit) refuses to reimburse Mounjaro, a drug against obesity marketed by the US pharmaceutical group Eli Lilly, reports Wednesday L'Echo. ...
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
